Contrast-enhanced ultrasound and liver imaging: Review of the literature;Performance de l'échographie de contraste en pathologie hépatique: Synthèse de la littérature

Journal de Radiologie

Volumn 90, Issue 1 C2, 2009, Pages 93-108

  Ladam Marcus, V ^a   Mac, G ^a   Job, L ^a   Piot Veron, S ^a   Marcus, C ^a   Hoeffel, C ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Contrast enhanced ultrasonography; Liver, tumor; Ultrasonography; Ultrasound contrast agents

Indexed keywords

BILE DUCT CARCINOMA; COLORECTAL CANCER; CONTRAST ENHANCED ULTRASOUND; FATTY LIVER; HUMAN; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER INJURY; LIVER METASTASIS; LIVER TUMOR; MICROBUBBLE; NODULAR HYPERPLASIA; REVIEW; SENSIBILITY; SENSITIVITY AND SPECIFICITY; ULTRASOUND;

EID: 60749093643     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(09)70087-3     Document Type: Article

References (78)

1. Bolondi L, Correas JM, Lencioni R, Weskott HP, Piscaglia F. New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. Dig Liver Dis 2007;39:187-95.
2. Tranquart F, Bleuzen A, Tchuenbou J. Echographie de contraste dans l'exploration des lésions focales hépatiques : valeur diagnostique et recommandations. J Radiol 2004;85:680-9.
3. Wilson SR, Burns PN. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography. AJR 2006;186:1401-12.
4. Leen E, Ceccotti P, Kalogeropoulou C et al. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography. AJR 2006;186:1551-9.
5. Quaia E, Calliada F, Bertolotto, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004;232:420-30.
6. Bartolotta TV, Taibbi A, Galia M et al. Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast-enhanced ultrasound. Eur Radiol 2007;17:650-61.
7. Dai Y, Chen MH, Yin SS et al. Focal liver lesions: can Sono Vue-enhanced ultrasound be used to differentiate malignant from benign lesions? Invest Radiol 2007;42:596-603.
8. Kim SH, Lee JM, Lee JY et al. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis. AJR 2005;184:1077-84.
9. Quaia E, D'Onofrio M, Cabassa P, et al. Diagnostic value of hepatocellular nodule vascularity after microbubble injection for characterizing malignancy in patients with cirrhosis. AJR 2007;189:1474-83.
10. Von Herbay A, Vogt C, Willers R, Häussinger D. Real-time imaging with the sonographic contrast agent Sonovue: Differentiation between benign and malignant hepatic lesions. J Ultrasound Med 2004;23:1557-68.
11. Wilson SR, Jang HJ, Kim TK, Burns PN. Diagnosis of focal liver masses on ultrasonography: Comparison of unenhanced and contrast-enhanced scans. J Ultrasound Med 2007;26:775-87.
12. Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images-concordance of US scans with CT scans and MR images. Radiology 2007; 242:162-74.
13. Catala V, Nicolau C, Vilana R et al. Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 2007;17:1066-73.
14. Dai Y, Chen MH, Fan E et al. Diagnosis of small hepatic nodules detected by surveillance ultrasound in patients with cirrhosis: Comparison between contrast-enhanced ultrasound and contrast-enhanced helical computed tomography. Hepatol Res 2008; 38:281-90.
15. Dietrich CF, Kratzer W, Strobel D et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006;12:1699-705.
16. Forner A, Vilana R, Ayuso C et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the non-invasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008;47:97-104
17. Quaia E, D'Onofrio M, Palumbo A et al. Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 2006;16:1599-609.
18. Ricci P, Laghi A, Cantisani V et al. Contrast-enhanced sonography with SonoVue: enhancement patterns of benign focal liver lesions and correlation with dynamic gadobenate dimeglumine-enhanced MRI. AJR 2005;184:821-7.
19. Tranquart F, Le Gouge A, Correas JM et al. Role of contrast-enhanced ultrasound in the blinded assessment of focal liver lesions in comparison with MDCT and CEMRI: Results from a multicentre clinical trial. Eur J Cancer 2008;6:9-15.
20. Wen YL, Kudo M, Zheng RQ et al. Characterization of Hepatic Tumors: Value of Contrast-Enhanced Coded Phase-Inversion Harmonic Angio. AJR 2004;182:1019-26.
21. Wilson SR, Kim TK, Jang HJ, Burns PN. Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR 2007;189: 7-12.
22. Jung EM, Clevert DA, Schreyer AG et al. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: A prospective controlled two-center study. World J Gastroenterol 2007;47:6356-64.
23. Claudon M, Cosgrove D, Albrecht T et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008.Ultraschall Med 2008;29:28-44.
24. Bleuzen A, Huang C, Olar M, Tchuenbou J, Tranquart F. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing. Ultraschall Med 2006;27:40-8.
25. Albrecht T, Blomley M, Bolondi L et al. Guidelines for the use of contrast agents in ultrasound. Consensus Conference on the use of Ultrasound Contrast Agents, Rotterdam, 2004. Ultraschall Med 2004;25:249-56.
26. Tranquart F, Claudon M, Correas JM. Recommandations pour l'utilisation des agents de contraste ultrasonores. J Radiol 2005;86:1047-54.
27. Albrecht T, Blomley MJ, Burns PN et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003;227:361-70.
28. Numata K, Isozaki T, Morimoto M et al. Prospective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography. World J Gastroenterol 2006;12:6290-98.
29. Xu HX, Liu GJ, Lu MD et al. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J clin Ultrasound 2006;34:261-72.
30. Celli N, Gaiani S, Piscaglia F et al. Characterization of liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 2007;19:3-14.
31. Dietrich CF, Schuessler G, Trojan J, Felbaum C, Ignee A. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005;78:704-7.
32. Kim TK, Jang JH. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR 2008;190:58-66.
33. Huang-Wei C, Bleuzen A, Bourlier P et al. Differential diagnosis of focal nodular hyperplasia with quantitative parametric analysis in contrast-enhanced sonography. Invest Radiol 2006;41:363-8.
34. Yen YH, Wang JH, Lu SN et al. Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia. Eur Radiol 2006;60:439-44.
35. Lin LW, Yang JJ, Lin XY et al. Effect of fatty liver background on contrast-enhanced ultrasonographic appearance of focal nodular hyperplasia. Hepatobiliary Pancreat Dis Int 2007;6:610-5.
36. Cokkinos DD, Blomley MJ, Harvey CJ, Lim A, Cunningham C, Cosgrove DO. Can contrast-enhanced ultrasonography characterize focal liver lesions and differentiate between benign and malignant, thus providing a one-stop imaging service for patients? Journal of Ultrasound 2007;10:186-93.
37. Lanka B, Jang HJ, Kim TK, Burns PN, Wilson SR. Impact of contrast-enhanced ultrasonography in a tertiary clinical practice. J Ultrasound Med 2007;26:1703-14.
38. Romanini L, Passamonti M, Aiani L et al. Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian experience. Eur Radiol 2007;17:S99-106.
39. Bouliac-Sage P, Rebouissou S, Thomas C et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46:740-8.
40. Laumonier H, Bioulac-Sage P, Laurent C et al. Hepatocellular adenomas: Magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008;16:808-18.
41. Gallix B, Aufort S. Incidentalomes. J Radiol 2007;88:1048-60.
42. Quaia E, Bartolotta TV, Midiri M, et al. Analysis of different contrast enhancement patterns after microbubble-based contrast agent injection in liver hemangiomas with atypical appearance on baseline scan. Abdom Imaging 2006;31:59-64.
43. Dietrich CF, Mertens JC, Braden B, et al. Contrast-enhanced ultrasound of histologically proven liver hemangiomas. Hepatology 2007;45:139-45.
44. Bartolotta TV, Taibbi A, Galia M et al. Centrifugal (inside-out) enhancement of liver hemangiomas: a possible atypical appearance on contrast-enhanced US. Eur J Radiol 2007;64:447-55.
45. Nicolau C, Vilana R, Catalá V et al. Importance of Evaluating All Vascular Phases on Contrast-Enhanced Sonography in the Differentiation of Benign from Malignant Focal Liver Lesions. AJR 2006;186:158-67.
46. Murphy-Lavallee J, Jang HJ, Kim TK, Burns PN, Wilson SR. Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography. J Ultrasound Med 2007;26:1545-56.
47. Konopke R, Kersting S, Berget H et al. Contrast-enhanced ultrasonography to detect liver metastases: a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 2007;22:201-7.
48. Piscaglia F, Corradi F, Mancini M et al. Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer. BMC cancer 2007;7:771.
49. Leen E, Ceccotti P, Moug SJ et al. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg 2006;243:236-40.
50. Torzilli G, Botea F, Procopio F et al. Use of contrast-enhanced intraoperative ultrasonography during liver surgery for colo rectal cancer liver metastases - Its impact on operative out come. Analysis of a prospective cohort study. Eur J Cancer 2008;6:16-23.
51. Menu Y, Bessoud B, Roche L et al. Lésions hépatiques en cancérologie. J Radiol 2007;88:1091-103.
52. Bruix J, Sherman M, Llover JM et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference. European Association for the Study of the Liver J Hepatol 2001;35:421-30.
53. Bruix J, Shermann M. AASLD Practice Guideslines, Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
54. Lencioni R, Della Pina C, Cioni D, Crocetti L. Guidelines for the use of contrast-enhanced ultrasound in hepatocellular carcinoma. Eur J Cancer 2008;6:1-8.
55. Luciani A, Allice O, Zegai B et al. Nodules sur foie de cirrhose: quelle imagerie? Pourquoi? Comment? J Radiol 2007;88:1073-90.
56. Gaiani S, Celli N, Piscaglia F et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004;41:421-6
57. Nicolau C, Catala V, Vilana R et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004;14:1092-99
58. Wen YL, Zhou P, Kudo M. Detection of intratumoral vascularity in small hepatocellular carcinoma by coded phase inversion harmonics. Intervirology 2004; 47:169-178
59. Chen MH, Yang W, Yan K. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Clin Radiol 2007; 62:752-60
60. Fan ZH, Chen MH, Dai Y et al. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: Correlation with pathology. AJR 2006; 186:1512-19
61. Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US : comparison with histologic differentiation. Radiology 2007; 244:898-906
62. Liu GJ, Xu HX, Lu MD et al. Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology. Br J Radiol 2007; 80:321-30
63. Lu MD, Yu XL, Li AH et al. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China. Ultrasound Med Biol 2007; 33:1736-49
64. Ogawa S, Kumada T, Toyoda H et al. Evaluation of pathological features of hepatocellular carcinoma by contrast-enhanced ultrasonography: comparison with pathology on resected specimen. Eur Radiol 2006; 59:74-81
65. Xu HX, Xie XY, Lu MD et al. Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or = 2 cm. J Clin Ultrasound 2008; 36:257-66
66. Bolondi L, Gaiani S, Celli N et al. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005; 42:27-34
67. Torzilli G, Palmisano A, Del Fabbro D et al. Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis: is it useful or useless? A prospective cohort study of experience. Ann Surg Oncol 2007; 14:1347-55
68. D'Onofrio M, Vecchiato F, Cantisani V et al. Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging. Radiol Med 2008; 113:76-86
69. Kim CK, Choi D, Lim HK et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005; 56:66-7
70. Dill-Macky MJ, Asch M, Burns P, Wilson S. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. AJR 2006; 186:S287-95
71. Vilana R, Bianchi L, Varela M et al. Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 2006; 16:2454-62
72. Choi D, Lim HK, Lee WJ et al. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med 2003; 22:1163-72
73. Wen YL, Kudo M, Zheng RQ et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.AJR 2003;181:57-63
74. Wang JH, Lu SN, Tung HD et al. Flash-echo contrast sonography in the evaluation of response of small hepatocellular carcinoma to percutaneous ablation. J Clin Ultrasound 2006; 34:161-8
75. Benjamin RS, Choi H, Macapinlac HA et al. We should desist using RECIST, at least in gastrointestinal stromal tumors. J Clin Oncol 2007; 25 : 1760-64
76. Piscaglia F, Gaiani S, Tamberi S et al. Liver metastases from rectal carcinoma: disease progression during chemotherapy despite loss of arterial-phase hypervascularity on real-time contrast-enhanced harmonic sonography at low acoustic energy. J Clin Ultrasound 2003; 31:387-91
77. Lassau N, Lamuraglia M, Chami L et al. Gastrointestinal Stromal Tumors Treated with Imatinib: Monitoring Response with Contrast-Enhance d Sonography. AJR 2006; 187:1267-1273
78. De Giorgi U, Aliberti C, Benea G, Conti M, Marangolo M. Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal tumors. Clin Cancer Res 2005; 11:6171-76.